期刊文献+

Fas/FasL凋亡系统与肿瘤免疫逃逸研究进展 被引量:19

Advancement of Fas/FasL Apoptosis System and Tumor Immune Evasion
暂未订购
导出
摘要 细胞凋亡是一种受细胞外环境和细胞内遗传物质调控的细胞自杀性死亡方式,是细胞自然衰老、死亡的一种方式,又称程序性细胞死亡。肿瘤细胞也存在凋亡,其凋亡受到基因表达、细胞因子、激素、放射线、药物等因素的影响。Fas/FasL系统是肿瘤细胞凋亡的重要途径之一,通过影响肿瘤细胞的Fas/FasL表达可以诱导其凋亡。现就Fas/FasL凋亡系统与肿瘤免疫逃逸的研究进展进行综述,并针对Fas系统在口腔鳞癌方面的应用进行深入探讨。 Apoptosis is a mode of physiological cell death regulated by extracellular microenvironment and intracellular heredity factors,in which the cells actively participate in their own death process.The balance of cell proliferation and death is important in maintaining normal tissue homeostasis.Apoptosis can occur in tumor cells,and its apoptosis is regulated by many factors,such as gene expression,influence of growth factors,glucocorticoid,X-ray,drugs and so on.The Fas/Fas ligand(FasL) pathway has been shown to be an important cellular pathway mediating apoptosis.The regulation of the expression of Fas/FasL in tumor cell can induce its apoptosis.In this article,the advancement of Fas/FasL apoptosis system and tumor immune evasion was reviewed as well as the role of Fas/FasL system in oral squamous cell carcinoma(OSCC).
作者 孙麟 陈乔尔
出处 《医学综述》 2008年第6期833-835,共3页 Medical Recapitulate
关键词 FAS FASL 细胞凋亡 免疫逃逸 Fas FasL Cell apoptosis Immune evasion
  • 相关文献

参考文献18

  • 1Griffith TS,Brunner T, Fletcher SM,et al. Fas ligand-induced apoptosis as a mechanism of immune privilege [ J ]. Science, 1995, 270 ( 5239 ) : 1189-1192.
  • 2向青,徐波,徐梅.Fas/FasL途径介导的人肺癌细胞免疫逃逸[J].中国病理生理杂志,2006,22(1):168-171. 被引量:15
  • 3邓清,袁宏银,熊斌,张明生.大肠癌中Fas、FasL、bcl-2蛋白的表达及意义[J].肿瘤防治研究,2003,30(2):127-129. 被引量:3
  • 4Husain N,Chiocca EA. Co-expression of Fas and Fas ligand in malignant glial tumors and cell lines [ J ]. Acta Neuropathol Berl, 1998,95 (3) :287-290.
  • 5宿杰,田大力,陈东义,张林,孙丽华.Fas/FasL在小细胞肺癌和转移淋巴结中的表达及临床意义[J].中国医科大学学报,2006,35(3):282-283. 被引量:5
  • 6刘晓红,王心明,王延龄.Fas/FasL在乳腺疾病发生发展过程中作用的研究[J].中国实验诊断学,2007,11(2):158-162. 被引量:10
  • 7Strater J, Hinz U ,Hasel C ,et al. Impaired CD95 expression predisposes for recurrence in curatively resected colon carcinoma: clinical evidence for immunoselection and CD95 L mediated control of minimal residual disease [ J ]. Gut,2005,54 (5) :661-665.
  • 8Munakata S, Watanabe O, Ohashi K, et al. Expression of FasL and Bcl-2 in cervical carcinoma and their prognostic significance [ J ]. Am J Clin Pathol,2005,123 (6) :879-885.
  • 9Reimer T, Kocran D, Muller H, et al. Tumor Fas ligand : Fas ratio greater than 1 is an independent marker of relative resistance to tamoxifen therapy in hormone receptor positive breast cancer [ J ]. Breast Cancer Res,2002,4(5) :R9.
  • 10Lee WC, Yu WC, Chen MF. Prognostic impact of Fas llgand on hepatocellular carcinoma after hepatectomy [ J]. World J Surg, 2004,28(8) :792-796.

二级参考文献27

共引文献32

同被引文献263

引证文献19

二级引证文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部